Aua Capital Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Aua Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$23.54 - $31.39 $776 - $1,035	-33 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$26.72 - $33.19 $213 - $265	8 Added 32.0%	33 $1,000
Q1 2021 May 11, 2021	SELL	$24.15 - $31.45 $1,521 - $1,981	-63 Reduced 71.59%	25 $1,000
Q4 2020 Feb 09, 2021	BUY	$17.7 - $25.81 $212 - $309	12 Added 15.79%	88 $2,000
Q3 2020 Nov 12, 2020	BUY	$20.2 - $25.05 $1,535 - $1,903	76 New	76 $2,000

257

57.3M

84.1K

61.2K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.62B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Aua Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aua Capital Management, LLC with notifications on news.